Enabling
Regenerative Medicine

Our ApoGraft™ technology turns production of stem cells into a simple, safe and inexpensive process

Learn more about Cellect

Understanding Cellect in 2 minutes

Key Milestones

JAN 2017

US Patent
Notice of Allowance

FEB 2017

First Cancer Patient Treated In Phase I/II Trial
Positive Clinical Results

MAR 2017

Successful First Cancer Patient Stem Cell Transplant

JUN 2017

Cellect Receives
Russian Patent

SEP 2017

FDA Grants Cellect Orphan Drug Status for ApoGraft™

JAN 2018

Positive Clinical Trial Results
100% Acceptance and Zero Related Adverse Events

JAN  2018

Opening 2nd Clinical Trial Site
DSMB Approves Dose Escalation

APR 2018

Successfully completes POC testing for scalable production of ApoTainer™

JUL  2018

Signs Collaboration Agreement with Dresden University

AUG 2018

Cellect Granted Key European Patent for Stem Cells Selection Technology

AUG  2018
Korean Patent
Notice of Allowance

The People Behind our Company

Our Advisory Board

Prof. SUSAN ALPERT
Ex FDA
Prof. COREY CUTLER
Harvard Medical School
Prof. JOHN F. DiPERSIO
Washington University
Prof. DOV ZIPORI
Weizmann Institute of Science
Prof. ROBERT S. NEGRIN
Stanford University

Our Board of Directors

Mrs. RUHAMA ABRAHAM
Ex Deputy Knesset Speaker
DAVID BRAUN
Merck
Dr. MICHAEL BERELOWITZ
Ex Pfizer
Dr. RUTH BEN YAKAR
PhD
ABRAHAM NAHMIAS
C.P.A, B.A

Our Management

Dr. Shai Yarkoni
Co-Founder & CEO
Nuriel Chirich Kasbian
Co-Founder & Executive Chairman
Eyal Leibovitz
CFO
Andrew Sabatier
Chief Business Officer
Dr. Ronit Bakimer-Kleiner
Chief Development Officer

Cellect Principles Simplified

Regenerative medicine

It is all about replacing damaged tissues and organs instead of "fixing" them with drugs and radiations

Regrowth of organs and tissues is no longer a science fiction

Stem cells are the building blocks....

... but they are extremely rare and difficult to cultivate

The process takes weeks in specialty labs, remains highly ineffective and its costs keep stem cell treatments a privilege of the elitist-few who can afford it

Cellect changes all that.

We enable safe and effective stem cells selection within hours and at a fraction of the cost - for all people

We make stem cells based regenerative medicine possible on mass scale

ENABLING STEM CELLS